Craft
  • Home
  •  / Daewoong Pharmaceutical
Daewoong Pharmaceutical

Daewoong Pharmaceutical

Revenue

₩1.5 T

FY, 2021

Market Capitalization

₩1.6 T

2022-11-21

Daewoong Pharmaceutical Summary

Company summary

Overview
Daewoong Pharmaceutical is a healthcare company that provides pharmaceutical solutions and services. It offers products in therapeutic areas, such as endocrinology, central nervous system, musculoskeletal, nephrology, antineoplastic, cardiovascular, and other diseases.
Type
Public
Status
Active
Founded
1945
HQ
KR | view all locations
Website
https://www.daewoong.co.kr
Sectors

LocationsView all

1 location detected

  • Seoul HQ

    Korea (Republic of)

    12 Bongeunsa-ro 114-gil, Gangnam-gu

Daewoong Pharmaceutical Financials

Summary financials

Revenue (Q2, 2022)
₩422.1B
Gross profit (Q2, 2022)
₩269.6B
Net income (Q2, 2022)
₩40.1B
Cash (Q2, 2022)
₩183.5B
EBIT (Q2, 2022)
₩58.6B
Enterprise value
$1.9T

Footer menu